Temblor, Brenda C.
HRN: 26-84-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/25/2025
04/14/2025
IV
3.375mg
Q6h
CAPHR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes